封面
市场调查报告书
商品编码
1624389

全球胆固醇筛检/胆固醇实验室检测服务市场规模(按客户类型、地区、范围和预测)

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Size By Type Of Customer, By Competitive Landscape, By Geography Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

胆固醇筛检/胆固醇实验室检测服务市场规模与预测

2020 年胆固醇筛检/胆固醇实验室检测服务市场规模价值 154 亿美元,预计到 2028 年将达到 286 亿美元,2021 年至 2028 年的复合年增长率为 7.9%。

心血管疾病和肥胖症的盛行率不断上升、医生更倾向于实验室检测而非自我检测、政府努力提高检测品质以及老龄人口的快速增长,这些因素都促使胆固醇筛检的减少。/推动胆固醇筛检成长的因素胆固醇实验室检测服务市场。全球胆固醇筛检/胆固醇实验室检测服务市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

全球胆固醇筛检/胆固醇实验室检测服务市场定义

久坐生活方式的盛行预计将增加全球对胆固醇实验室检测的需求。胆固醇是一种蜡状、脂肪状物质,存在于血液、神经纤维和身体器官中。一个人的胆固醇水平取决于遗传、食用富含饱和脂肪的食物(如动物产品)、代谢疾病(如糖尿病)、年龄和性别等因素。

全球胆固醇筛检/胆固醇实验室检测服务市场概况

胆固醇水平升高会增加健康风险,包括增加中风和心臟病的风险,并且是促使死亡的主要原因。胆固醇实验室测试能够及早发现问题,避免併发症并增加患者生存的机会,从而推动胆固醇筛检/胆固醇实验室测试服务市场的成长。

其他推动市场成长的关键因素包括:人们对胆固醇危害的认识不断提高,以及对胆固醇检测重要性的教育不断加强,心血管疾病、中风和其他心臟疾病的盛行率不断上升,以及医疗保健支出不断增加。低、偏好快餐以及缺乏体能训练)等因素的推动。

肥胖也是一种与高胆固醇有关的疾病。随着与胆固醇相关的疾病的增加,对此类检测的需求也将增加,从而扩大全球实验室胆固醇检测市场。然而,由于非侵入性胆固醇检测方法的引入以及家庭或自我检测试剂盒的存在,可能会限製成长。

目录

第1章全球胆固醇筛检/胆固醇实验室检测服务市场:简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章:经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第4章 全球胆固醇筛检/胆固醇实验室检测服务市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析

第5章 全球胆固醇筛检/胆固醇实验室检测服务市场(依客户类型)

  • 概述
  • 医生/医疗服务提供者和医院
  • 政府机构
  • 诊断中心
  • 患者
  • 其他
第6章全球胆固醇筛检/胆固醇实验室检测服务市场(按地区)
  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第7章 全球胆固醇筛检/胆固醇实验室检测服务市场:竞争格局

  • 概述
  • 公司市占率
  • 供应商概况
  • 主要发展策略

第 8 章 公司简介

  • Laboratory Corporation of America Holdings(LabCorp)
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Spectra Laboratories, Inc.
  • Unilabs
  • Synlab International GmbH
  • Bio-Reference Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • ACM Medical Laboratory
  • Adicon Clinical Laboratory

第9章 附录

  • 相关报告
简介目录
Product Code: 24129

Cholesterol Screening/Cholesterol Lab Testing Services Market Size And Forecast

Cholesterol Screening/Cholesterol Lab Testing Services Market size was valued at USD 15.4 Billion in 2020 and is projected to reachUSD 28.6 Billion by 2028, growing at aCAGR of 7.9% from 2021 to 2028.

The increased incidence of cardiovascular disease and obesity, doctors' preference for laboratory testing over self-testing, government initiatives to improve test quality, and the rapid growth of the geriatric population are driving the growth of the Cholesterol Screening/Cholesterol Lab Testing Services Market. The Global Cholesterol Screening/Cholesterol Lab Testing Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Definition

The pervasiveness of inactive lifestyles is expected to increase the demand for cholesterol laboratory tests around the world. Cholesterol is a waxy, fat-like substance that is present in the bloodstream, in nerve fibers, and body organs. A person's cholesterol level is determined by factors such as heredity, consumption of foods high in saturated fatty acids like animal products, and metabolic diseases such as diabetes, age, and gender.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Overview

Elevated cholesterol level increases health risks such as a high risk of stroke and heart disease, which are responsible for a large number of deaths. Cholesterol laboratory tests enable problems to be detected early, avoid complications and increase the patient's chances of survival which drives the growth of the Cholesterol Screening/Cholesterol Lab Testing Services Market.

Other important drivers of market growth are the gradual awareness of the dangers of cholesterol and education about the importance of these tests, the increasing incidence of cardiovascular diseases, strokes, and other heart diseases, the growth in health care spending, government initiatives, the increase in the geriatric population and technological advances in cholesterol laboratory testing services, low consumption of fruits and vegetables, unhealthy food habits such as liking for fast food and fast food, and lack of physical inactivity have fueled the growth of this market.

Obesity is another condition related to high cholesterol. As the number of cholesterol-induced diseases increases, so will the need for these tests, expanding the market for global laboratory cholesterol testing. However, the presence of home or self-test kits could restrict the growth in addition to the limitations imposed by the introduction of non-invasive cholesterol testing procedures.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Segmentation Analysis

The Global Cholesterol Screening/Cholesterol Lab Testing Services Market is Segmented on the basis of Type of Customer And Geography.

Cholesterol Screening/Cholesterol Lab Testing Services Market, By Type Of Customer

  • Physicians/Providers and Hospitals
  • Government Agencies
  • Diagnostic centers
  • Patients
  • Others

Based on Type Of Customer, The market is segmented into Physicians/Providers and Hospitals, Government Agencies, Diagnostic centers, Patients, and Others. Diagnostic Centres dominated the market in terms of total revenue share and are also expected to have the fastest CAGR during the forecast period due to the increasing number of people diagnosed with high total cholesterol. Furthermore, regular health checkups without the doctors' Interventions are also a powerful driver of growth. The Government segment is expected to experience significant growth in the forecast period due to its increasing focus on prevention and early detection to avoid serious illnesses.

Cholesterol Screening/Cholesterol Lab Testing Services Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Cholesterol Screening/Cholesterol Lab Testing Services Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the global Cholesterol Screening/Cholesterol Lab Testing Services Market, with the United States having a significant share. Asia is projected to be the fastest-growing region in terms of CAGR. Due to the large population base, increased prevalence of cardiovascular disease, and a growing number of testing facilities in the Asia region over the forecast period.

Key Players

  • The "Global Cholesterol Screening/Cholesterol Lab Testing Services Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Spectra Laboratories, Inc., Unilabs, Synlab International GmbH, Bio-Reference Laboratories, Inc., Clinical Reference Laboratory, Inc., ACM Medical Laboratory, and Adicon Clinical Laboratory.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET, BY TYPE OF CUSTOMER

  • 5.1 Overview
  • 5.2 Physicians/Providers and Hospitals
  • 5.3 Government Agencies
  • 5.4 Diagnostic centers
  • 5.5 Patients
  • 5.6 Others

6 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET, BY GEOGRAPHY

  • 6.1 Overview
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
    • 6.2.3 Mexico
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 U.K.
    • 6.3.3 France
    • 6.3.4 Rest of Europe
  • 6.4 Asia Pacific
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Rest of Asia Pacific
  • 6.5 Rest of the World
    • 6.5.1 Latin America
    • 6.5.2 Middle East & Africa

7 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET COMPETITIVE LANDSCAPE

  • 7.1 Overview
  • 7.2 Company Market Share
  • 7.3 Vendor Landscape
  • 7.4 Key Development Strategies

8 COMPANY PROFILES

  • 8.1 Laboratory Corporation of America Holdings (LabCorp)
    • 8.1.1 Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Outlook
    • 8.1.4 Key Developments
  • 8.2 Quest Diagnostics Incorporated
    • 8.2.1 Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Outlook
    • 8.2.4 Key Developments
  • 8.3 Eurofins Scientific
    • 8.3.1 Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Outlook
    • 8.3.4 Key Developments
  • 8.4 Spectra Laboratories, Inc.
    • 8.4.1 Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Outlook
    • 8.4.4 Key Developments
  • 8.5 Unilabs
    • 8.5.1 Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Outlook
    • 8.5.4 Key Developments
  • 8.6 Synlab International GmbH
    • 8.6.1 Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Outlook
    • 8.6.4 Key Developments
  • 8.7 Bio-Reference Laboratories, Inc.
    • 8.7.1 Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Outlook
    • 8.7.4 Key Developments
  • 8.8 Clinical Reference Laboratory, Inc.
    • 8.8.1 Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product Outlook
    • 8.8.4 Key Developments
  • 8.9 ACM Medical Laboratory)
    • 8.9.1 Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Outlook
    • 8.9.4 Key Developments
  • 8.10 Adicon Clinical Laboratory
    • 8.10.1 Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Outlook
    • 8.10.4 Key Developments

9 Appendix

  • 9.1 Related Reports